Keywords:
COVID19, Fungal metabolites, Anti-viral, Molecular docking, Molecular dynamics
The COVID-19 crisis prompted the rapid determination of protein structures using homologous modelling from SARS-CoV data. Drug repurposing is a promising strategy, leveraging existing research to identify potential compounds for treatment amidst the urgency of the pandemic. Based on the involvement in virus replication as well as anticipated non-interactive capability to attach with any target proteins of the virus, main protease (Mpro) is regarded as a potential antiviral therapeutic molecule among all other reported structures connected to SARS-CoV-2. Fungal metabolites are a reservoir of bioactive molecules that could be used for treating this new COVID-19 virus and minimal research on the same has been carried out to date. Thus, in this study, the aim is to identify possible naturally obtained fungal metabolites that can interact as well as decrease the activities of the Mpro receptor using in-silico analysis. Forty-five compounds possessing antiviral activity were taken for inspection and were further analyzed via Lipinski’s rule. Further, on executing molecular docking and dynamic studies on selected compounds, Sansalvamide A and ergosterol-5,8-peroxide are proposed to be a potential inhibitor of the Mpro receptor as they showed the least binding energy of − 9.01 kcal/mol and − 8.97 kcal/mol respectively. In molecular dynamics simulations, Ergosterol-5,8-peroxide showed stable RMSD values (maximum deviation: 2.4 Å), indicating protein stability, while Sansalvamide A exhibited fluctuating RMSD values (maximum deviation: 2.8 Å). Sansalvamide A displayed consistent interaction dynamics with GLU166, forming hydrogen bonds and water bridges, whereas Ergosterol-5,8-peroxide primarily interacted with GLY143 and SER144 through hydrogen bonding. Sansalvamide A demonstrated superior secondary structure element (SSE) formation (41.58%) compared to Ergosterol-5,8-peroxide (37.12%). This indicates that both the compounds are the probable inhibitors of Mpro receptor and they should undergo in-vitro studies to support these assertions.
(*Only SPR Life Members can get full access.)
Abdel-Wareth, M.T.A. (2021). Fungal Secondary Metabolites: Current Research, Commercial Aspects, and Applications. In: Abdel-Azeem, A.M., Yadav, A.N., Yadav, N., Sharma, M. (eds) Industrially Important Fungi for Sustainable Development. Fungal Biology. Springer, Cham. https://doi.org/10.1007/978-3-030-85603-8_8
Aly AH, Debbab A, Proksch P (2011) Fifty years of drug discovery from fungi. Fungal Divers 50:3–19
Bai Y et al (2020) Presumed asymptomatic carrier transmission of COVID-19. JAMA. https://doi.org/10.1001/jama.2020.2565
Beckmann AM, Barrow RA (2014) Fungal metabolites as pharmaceuticals. Aust J Chem 67:827–843
Bills, G. F., & Gloer, J. B. (2016). Biologically Active Secondary Metabolites from the Fungi. Microbiology Spectrum, 4(6). https://doi.org/10.1128/microbiolspec.funk-0009-2016
Campanini Maciel, O. M., Napoleão Tavares, R. S., Engracia Caluz, D. R., Rigo Gaspar, L. & Debonsi, H. M. Photoprotective potential of metabolites isolated from algae-associated fungi Annulohypoxylon stygium. J. Photochem. Photobiol. B Biol. 178, 316–322 (2018).
Celik, I., Rudrapal, M., Yadalam, P. K., Chinnam, S., Balaji, T. M., Varadarajan, S., ... & Panke, D. V. (2022). Resveratrol and Its Natural Analogues Inhibit RNA Dependant RNA Polymerase (RdRp) of Rhizopus oryzae in Mucormycosis through Computational Investigations. Polycyclic Aromatic Compounds, 1–18.
Meera Christopher, Prajeesh Kooloth-Valappil, Athiraraj Sreeja-Raju, Rajeev K. Sukumaran, Repurposing proteases: An in-silico analysis of the binding potential of extracellular fungal proteases with selected viral proteins, Bioresource Technology Reports, Volume 15, 2021, 100756, ISSN 2589-014X, https://doi.org/10.1016/j.biteb.2021.10075
Colla LM, Ficantha AMM, Rizzardi J et al (2015) Production and characterization of lipases by two new isolates of Aspergillus through solid-state and submerged fermentation. BioMed Res Int. Article ID 725959
Dai, W., Zhang, B., Jiang, X.-M., Su, H., Li, J., Zhao, Y., Xie, X., Jin, Z., Peng, J., Liu, F., Li, C., Li, Y., Bai, F., Wang, H., Cheng, X., Cen, X., Hu, S., Yang, X., Wang, J., … Liu, H. (2020). Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease. Science (New York, N.Y.).), 368(6497), 1331–1335. https://doi.org/10.1126/science.abb4489
Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7(1):42717. https://doi.org/10.1038/srep42717
Das, S., Sarmah, S., Lyndem, S., & Singha, R. A. (2020). An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study. Journal of Biomolecular Structure and Dynamics, 1–11. https://doi.org/10.1080/07391102.2020.1763201
Dufosse L, Fouillaud M, Caro Y et al (2014) Filamentous fungi are large-scale producers of pigments and colorants for the food industry. Curr Opin Biotechnol 26:56–61
Galappaththi MCA, Patabendige NM, Premarathne BM, Hapuarachchi KK, Tibpromma S, Dai D, Suwannarach N, Rapior S, Karunarathna SC (2022) A review of ganoderma triterpenoids and their bioactivities. Biomolecules 13(1):24. https://doi.org/10.3390/biom13010024
Gao L et al (2018) Identification of novel sesterterpenes by genome mining of phytopathogenic fungi Phoma and Colletotrichum sp. Tetrahedron Lett 59:1136–1139
Ghosh, R., Chakraborty, A., Biswas, A., & Chowdhuri, S. (2020). Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors–an in silico docking and molecular dynamics simulation study. Journal of Biomolecular Structure and Dynamics, 1–13. https://doi.org/10.1080/07391102.2020.1779818v
Goel RK, Singh D, Lagunin A, Poroikov V (2011) PASS-assisted exploration of new therapeutic potential of natural products. Med Chem Res 20(9):1509–1514. https://doi.org/10.1007/s00044-010-9398-010-9398-y
Gulzar M, Syed SB, Khan FI, Khan P, Ali S, Hasan GM, Taneja P, Hassan MI (2019) Elucidation of interaction mechanism of ellagic acid to the integrin linked kinase. Int J Biol Macromol 122:1297–1304. https://doi.org/10.1016/j.ijbiomac.2018.09.089
Jamzivar F, Shams-Ghahfarokhi M, Khoramizadeh M, Yousefi N, Gholami-Shabani M, Razzaghi-Abyaneh M (2019) Unraveling the importance of molecules of natural origin in antifungal drug development through targeting ergosterol biosynthesis pathway. Iran J Microbiol 11:448–459
Jin, J. M.; Bai, P.; He, W.; Wu, F.; Liu, X.F.; Han, D.M.; Liu, S.; Yang, J.K. Gender Differences in Patients With COVID-19: Focus on Severity and Mortality. Frontiers in public health. 2020, 8, 152. https://doi.org/10.3389/fpubh.2020.00152
Joshi, R. S., Jagdale, S. S., & Bansode, S. B. (2020). Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease. Journal of Biomolecular Structure and Dynamics, 1–16. https://doi.org/10.1080/07391102.2020.1760137
Kong R, Yang G, Xue R, Liu M, Wang F, Hu J, Guo X, Chang S (2020) COVID-19 Docking Server: A meta server for docking small molecules, peptides and antibodies against potential targets of COVID-19. Bioinformatics. https://doi.org/10.1093/bioinformatics/btaa645
Kramer R, Abraham W-R (2012) Volatile sesquiterpenes from fungi: what are they good for? Phytochem Rev 11:15–37
Lipinski CA (2004) Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol 1(4):337–341. https://doi.org/10.1016/j.ddtec.2004.11.007
Luthra R, Kaur S, Bhandari K. Applications of CRISPR as a potential therapeutic. Life Sci. 2021 Nov 1;284:119908. doi: https://doi.org/10.1016/j.lfs.2021.119908. Epub 2021 Aug 25.
Manzoni M, Rollini M (2002) Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs. Appl Microbiol Biotechnol 58:555–564
Nasir N, Farooqi J, Mahmood SF, Jabeen K (2020) COVID−19−associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID−19 pneumonia: an observational study from Pakistan. Mycoses 63:766–770
Neupane A, Feng C, Feng J, Kafle A, Bücking H, Lee Marzano SY. Metatranscriptomic Analysis and In Silico Approach Identified Mycoviruses in the Arbuscular Mycorrhizal Fungus Rhizophagus spp. Viruses. 2018;10(12):707. Published 2018 Dec 12. https://doi.org/10.3390/v10120707
Noumeur SR et al (2017) Preussilides A—F, Bicyclic Polyketides from the Endophytic Fungus Preussia similis with Antiproliferative Activity. J Nat Prod 80:1531–1540
Patel R, Vanzara A, Patel N, Vasava A, Patil S, Rajput K. Discovery of Fungal Metabolites Bergenin, Quercitrin and Dihydroartemisinin as Potential Inhibitors Against Main Protease of SARS-CoV-2. ChemRxiv. Cambridge: Cambridge Open Engage; 2020
Rao P, Shukla A, Parmar P, Rawal RM, Patel B, Saraf M, Goswami D (2020) Reckoning a fungal metabolite, Pyranonigrin A as a potential Main protease (Mpro) inhibitor of novel SARS-CoV-2 virus identified using docking and molecular dynamics simulation. Biophys Chem 264:106425. https://doi.org/10.1016/j.bpc.2020.106425
Rao P, Shukla A, Parmar P, Rawal RM, Patel BV, Saraf M, Goswami D (2020) Proposing a fungal metabolite-flaviolin as a potential inhibitor of 3CLpro of novel coronavirus SARS-CoV-2 identified using docking and molecular dynamics. J Biomol Struct Dyn 2:1–13. https://doi.org/10.1080/07391102.2020
Refer: https://covid19.who.int
Rothe C et al (2020) Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med 382:970–971
Sadeghi G, Ebrahimi-Rad M, Mousavi S, Shams-Ghahfarokhi M, Razzaghi-Abyaneh M (2018) Emergence of non-Candida albicans species: epidemiology, phylogeny and fluconazole susceptibility profile. J Mycol Med 28:51–58
Sattar NA et al (2014) The use of statins in people at risk of developing diabetes mellitus: Evidence and guidance for clinical practice. Atheroscler Suppl 15:1–15
Shreeja D, Arpita R (2020) Neurological manifestation and treatment strategies of COVID-19: a review. Res J Biotechnol 15:135–145
Stoev SD (2015) Foodborne mycotoxicoses, risk assessment and underestimated hazard of masked mycotoxins and joint mycotoxin effects or interaction. Environ Toxicol Pharmacol 39:794–809
Sułkowska-Ziaja K, Trepa M, Olechowska-Jarząb A, Nowak P, Ziaja M, Kała K, Muszyńska B (2023) Natural Compounds of Fungal Origin with Antimicrobial Activity—Potential Cosmetics Applications. Pharmaceuticals (basel) 16(9):1200. https://doi.org/10.3390/ph16091200
Talento AF, Hoenigl M (2020) Fungal infections complicating COVID-19: with the rain comes the spores. J Fungi 6:279
Valverde ME, Hernández-Pérez T, Paredes-López O (2015) Edible mushrooms: improving human health and promoting quality life. Int J Microbiol. Article ID 376387
Velišek J, Cejpek K (2011) Pigments of higher fungi—a review. Czech J Food Sci 29:87–102
Wang W et al (2018) Antimicrobial activity and molecular docking studies of a novel anthraquinone from a marine- derived fungus Aspergillus versicolor. Nat Prod Res 6419:558–563
Wang C, Horby PW, Hayden FG, Gao GF (2020) A novel coronavirus outbreak of global health concern. Lancet 395:470–473
Wang, D.; Hu, B.; Hu, C.; Zhu, F.; Liu, X.; Zhang, J.; et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. Jama. 2020
Zhu N et al (2020) A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382:727–733